Justera Health Announces RSU Grant
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announced the approval of 23 million restricted share units (RSUs) under its omnibus incentive plan. The RSUs, granted to employees, directors, and consultants, will vest in three stages: 50% immediately, 25% after three months, and the remaining 25% after six months from issuance. This initiative aims to retain skilled personnel and align their interests with shareholders.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) ha annunciato l'approvazione di 23 milioni di unità di azioni riservate (RSU) nell'ambito del suo piano di incentivazione omnibus. Le RSU, concesse a dipendenti, direttori e consulenti, si acquisiranno in tre fasi: 50% immediatamente, 25% dopo tre mesi e il restante 25% dopo sei mesi dalla concessione. Questa iniziativa ha l'obiettivo di trattenere personale qualificato e allineare i loro interessi a quelli degli azionisti.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) anunció la aprobación de 23 millones de unidades de acciones restringidas (RSUs) bajo su plan de incentivos omnibus. Las RSUs, otorgadas a empleados, directores y consultores, se adquirirán en tres etapas: 50% inmediatamente, 25% después de tres meses y el restante 25% después de seis meses a partir de la emisión. Esta iniciativa tiene como objetivo retener personal calificado y alinear sus intereses con los de los accionistas.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF)는 2,300만 제한 주식 단위 (RSUs)의 승인을 발표했습니다. RSU는 직원, 이사 및 컨설턴트에게 제공되며, 세 단계로 부여됩니다: 50% 즉시, 25% 3개월 후, 그리고 나머지 25% 6개월 후에 발급됩니다. 이 이니셔티브는 숙련된 인력을 유지하고 그들의 이익을 주주와 일치시키는 것을 목표로 합니다.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) a annoncé l'approbation de 23 millions d'unités d'actions réservées (RSUs) dans le cadre de son plan d'incitation omnibus. Les RSUs, accordées aux employés, directeurs et consultants, seront acquises en trois étapes : 50% immédiatement, 25% après trois mois et les 25% restants après six mois suivant l'attribution. Cette initiative vise à retenir des personnes qualifiées et à aligner leurs intérêts avec ceux des actionnaires.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) gab die Genehmigung von 23 Millionen eingeschränkten Aktieneinheiten (RSUs) im Rahmen seines omnibus Anreizplans bekannt. Die RSUs, die an Mitarbeiter, Direktoren und Berater gewährt werden, werden in drei Phasen erworben: 50% sofort, 25% nach drei Monaten und die verbleibenden 25% nach sechs Monaten ab Ausstellungsdatum. Diese Initiative zielt darauf ab, qualifiziertes Personal zu halten und ihre Interessen mit denen der Aktionäre in Einklang zu bringen.
- Implementation of employee retention strategy through RSU grants
- Structured vesting schedule to ensure long-term alignment with company goals
- Potential shareholder dilution from 23 million new RSUs
- 50% immediate vesting may not provide optimal long-term retention incentive
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") is pleased to announce that its Board of Directors has approved the issuance of 23,000,000 restricted share units ("RSUs") under the Company's omnibus incentive plan (the "Plan") on November 7, 2024. These RSUs have been awarded to employees, directors, and consultants of the Company as part of a strategy to retain skilled personnel and align their interests with those of the Company's shareholders. The RSUs will vest in stages:
About Justera Health
Established in 2020, Justera is a Canadian company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.
For additional information on Justera Health and other corporate information, please visit the Company's website at https://www.justerahealth.com/
For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.
For further information:
Investor Relations & Communications
Paul Haber, CFO
Tel: (416) 318-6501
Email: info@justerahealth.com
Forward-Looking Statements:
Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. All statements included herein, other than statements of historical fact, are forward-looking statements, including but not limited to: the terms, timing and completion of the Transaction, if the Transaction is to close at all, the receipt of all necessary regulatory and CSE approvals, authorizations and consents in connection with the Transaction, and the completion or waiver, as applicable, of all conditions precedent required for the completion of the Transaction; the anticipated business plans, management structure, and future activities of the Company and Port North, including the Company's intention to integrate Port North into its business; and the anticipated benefits and synergies to be derived from the Transaction on the business of both Port North and the Company; and the date in which the Payment Shares may become free-trading.
Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: (i) successful completion of the Financing; (ii) successful completion of the Transaction and the integration of the business of Port North in connection therewith; (iii) the ability to manage anticipated and unanticipated costs; (iv) achieving the anticipated results of the Company's strategic plans; (v) obtaining and maintaining all required licenses, approvals and permits, including regulatory approvals required to complete the Transaction; and (vi) general economic, financial market, regulatory and political conditions in which the Company operates.
Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of the inability of Port North to complete the Financing, the inability to consummate the Transaction, including the inability to obtain required regulatory approvals and third-party consents and the satisfaction of other conditions, inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; changes in general economic, business and political conditions, including changes in the financial markets, changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera's strategic growth plans, and other factors, many of which are beyond the control of Justera.
Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera's expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Justera Health Ltd.
View the original press release on accesswire.com
FAQ
How many RSUs did Justera Health (SCRSF) issue on November 7, 2024?
What is the vesting schedule for Justera Health's (SCRSF) RSU grant announced in November 2024?
Who are the recipients of Justera Health's (SCRSF) November 2024 RSU grant?
